Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Ian Churcher

Ian Churcher, Herts GB

Patent application numberDescriptionPublished
20090192155Identification of Compounds Suitable for Treating Ad - The invention provides a method of screening for compounds which inhibit the hyperphosphorylation of tau, and hence are suitable for treating AD and related conditions.07-30-2009
20090247504Indazole Derivatives for Treatment of Alzheimer's Disease - Compounds of formula (IA) and (IB) are inhibitors of MARK, and hence are suitable for treatment of Alzheimer's disease.10-01-2009
20100234463Method for Identifying Modulators of Gamma Secretase or Notch - The present invention relates to methods for high throughput screening to identify selective modulators of γ-secretase. Such modulators selectively block γ-secretase activity without affecting Notch cleavage and signaling. Said methods employ the use of high content screening methodologies to measure and quantify the translocation of the Notch intracellular domain (NICD) between the nucleus and cytoplasm in cells and the activation of Notch.09-16-2010
20100240647Treatment of Alzheimer's Disease and Related Conditions - Compounds of formula (I) inhibit microtubule affinity regulating kinase (MARK), and hence are suitable for treating diseases associated with abnormal phosphorylation of tau.09-23-2010

Ian Churcher, Royston GB

Patent application numberDescriptionPublished
20080300261Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease - Compounds of formula I12-04-2008
20100048555IMIDAZOTHIAZOLE DERIVATIVES AS MARK INHIBITORS - Compounds of formula (I): are inhibitors of MARK, and hence useful for treatment of disorders involving 10 hyperphosphorylation of tau.02-25-2010

Patent applications by Ian Churcher, Royston GB

Ian Churcher, Hertfordshire GB

Patent application numberDescriptionPublished
20100009987AMINOTHIAZOLE DERIVATIVES AS INHIBITORS OF MARK - Compounds of formula (I): inhibit microtubule affinity regulating kinase (MARK) and therefore find use in treatment of neurodegenerative diseases associated with hyperphosphorylation of tau.01-14-2010

Ian Churcher, Great Dunmow GB

Patent application numberDescriptionPublished
20090131419Sulphones which modulate the action of gamma secretase - Disclosed are sulphones which modulate the action of gamma-secretase. The compounds are useful in the treatment or prevention of Alzheimer's disease.05-21-2009

Patent applications by Ian Churcher, Great Dunmow GB